Benzodiazepine receptor antagonists modulate the actions of ethanol in alcohol-preferring and -nonpreferring rats

European Journal of Pharmacology
Harry L JuneJ M Murphy

Abstract

The pyrazoloquinoline CGS 8216 (2-phenylpyrazolo-[4,3-c]-quinolin-3 (5H)-one, 0.05-2 mg/kg) and the beta-carboline ZK 93426 (ethyl-5-isopropyl-4-methyl-beta-carboline-3-carboxylate, 1-10 mg/kg) benzodiazepine receptor antagonists were evaluated for their capacity to modulate the behavioral actions of ethanol in alcohol preferring and -nonpreferring rats. When alcohol-preferring rats were presented with a two-bottle choice test between ethanol (10% v/v) and a saccharin (0.0125% g/v) solution, both antagonists dose-dependently reduced intake of ethanol by 35-92% of control levels on day 1 at the initial 15 min interval of the 4 h limited access. Saccharin drinking was suppressed only with the highest doses. CGS 8216 (0.25 mg/kg) and ZK 93426 (4 mg/kg) unmasked the anxiolytic effects of a hypnotic ethanol dose (1.5 g/kg ethanol) on the plus maze test in alcohol-preferring rats, but potentiated the ethanol-induced suppression in alcohol-nonpreferring rats. CGS 8216 (0.25 mg/kg) and ZK 93426 (4 mg/kg) attenuated the ethanol (0.5 and 1.5 g/kg)-induced suppression in the open field in alcohol-nonpreferring rats; however, CGS 8216 potentiated the depressant effects of the lower ethanol dose (0.5 g/kg) in alcohol-preferring rats. These ...Continue Reading

References

Jan 14, 1992·European Journal of Pharmacology·G Wong, P Skolnick
Mar 31, 1992·European Journal of Pharmacology·E R KorpiK Wegelius
Feb 1, 1992·Alcoholism, Clinical and Experimental Research·L J DraskiR A Deitrich
Jul 1, 1991·Pharmacology, Biochemistry, and Behavior·A W ChanF Penetrante
Feb 1, 1988·Pharmacology, Biochemistry, and Behavior·A W ChanL Aldrich-Castanik
Jan 1, 1985·Pharmacopsychiatry·W Haefely
Jan 1, 1986·Psychopharmacology·M JedrychowskiP R Bieck
Nov 1, 1986·British Journal of Clinical Pharmacology·U KlotzG Mikus
Sep 1, 1987·Pharmacology, Biochemistry, and Behavior·G J GattoT K Li
Feb 1, 1985·Cardiologia : bollettino della Società italiana di cardiologia·M FerrariG Cargnelli
Jan 1, 1985·European Neurology·G Scollo-Lavizzari, H Matthis
Jan 1, 1984·Psychopharmacology·L H JensenR Schmiechen
Oct 30, 1984·European Journal of Pharmacology·C L Brown, I L Martin
Dec 5, 1980·European Journal of Pharmacology·N R Oakley, B J Jones
Feb 19, 1982·European Journal of Pharmacology·P SkolnickS M Paul
Feb 1, 1983·Pharmacology, Biochemistry, and Behavior·S E File, R G Lister
Apr 9, 1981·Nature·W HunkelerW Haefely
Oct 8, 1982·Neuroscience Letters·S E FileD J Nutt
Jan 1, 1982·Psychopharmacology·E P BonettiW Haefely
Jan 1, 1983·Advances in Biochemical Psychopharmacology·C BraestrupT Honoré
Mar 15, 1984·Biochemical Pharmacology·C BraestrupL H Jensen
Mar 14, 1983·Neuroscience Letters·S E File
Jan 1, 1984·Alcohol·C M BeamanL D Reid
Nov 1, 1994·Alcohol·C GeroldiM Trabucchi

❮ Previous
Next ❯

Citations

Apr 21, 1999·Brain Research. Brain Research Reviews·A K Mehta, M K Ticku
May 20, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Harry L JuneGregg E Homanics
Dec 18, 2013·Alcoholism, Clinical and Experimental Research·Eileen K SawyerDonna M Platt
Jan 25, 2006·Pharmacology, Biochemistry, and Behavior·Bruce E Hetzler, Elizabeth I Martin
Jul 6, 2005·Pharmacology & Therapeutics·Esa R Korpi, Saku T Sinkkonen
Sep 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Harry L JunePhil Skolnick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.